UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
−Removed: We issued 24,901 shares of our common stock upon the cashless net exercise of a warrant to purchase 43,115 shares of our common stock during the three months ended March 31, 2021.
−Removed: The warrant was issued on May 18, 2016 in connection with the amendment of a previous loan agreement.
−Removed: We deemed the issuance of common stock upon the exercise of the warrant to be exempt from registration under the Securities Act pursuant to Section 3(a)(9) of the Securities Act.
−Removed: No underwriters were involved in the issuance of our common stock upon the exercise of the warrant and no commissions were paid in connection with such issuance.
−Removed: Platform Development Funding Agreement between Omeros Corporation and Vulcan Inc.
−Removed: and its affiliate dated October 21, 2010 (previously filed as Exhibit 10.44 from the Company’s Annual Report on Form 10-K filed on March 15, 2011)
−Removed: Grant Award Agreement between Omeros Corporation and the Life Sciences Discovery Fund Authority dated October 21, 2010 (previously filed as Exhibit 10.45 from the Company’s Annual Report on Form 10-K filed on March 15, 2011)
+Added: Thirteenth Amendment to Lease dated June 1, 2021 between Omeros Corporation and BMR-201 Elliott Avenue LLC
+Added: Omeros Corporation 2017 Omnibus Incentive Compensation Plan (as amended and restated effective June 11, 2021) (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on June 16, 2021).
Certification of Principal Executive Officer Pursuant to Rule 13-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 unchanged sentences
Cover Page Interactive Data File, formatted in Inline XBRL (included in Exhibit 101)
−Removed: † Confidential portions of this Exhibit were redacted pursuant to Item 601(b)(10) of Regulation S-K and the Company agrees to furnish supplementary to the Securities and Exchange Commission a copy of any redacted information or omitted schedule and/or exhibit upon request.
The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of Omeros Corporation under the Securities Act or the Exchange Act, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
1 unchanged sentence
OMEROS CORPORATION
+Added: August 9, 2021
/s/ Gregory A.
1 unchanged sentence
President, Chief Executive Officer and Chairman of the Board of Directors
+Added: August 9, 2021
/s/ Michael A.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.